Metabolomic Markers Predictive of Adverse Events Due to Acetaminophen Administration

  • Kennon Heard, MD, PhD

  • Susan Heardl Angelo D'Alessandro, PhD

  • Barry Rumack, MD

  • Andrew Monte, MD, PhD

    University of Colorado School of Medicine

    Andrew is trained as a medical toxicologist and has a PhD in Clinical Sciences with a focus in Genetics. He does research on novel psychoactive substances and precision medicine. He is the Director of the University of Colorado Emergency Medicine Specimen Bank which collects biologic samples from ED patients with a goal of improving emergency therapies through genomic and metabolomic methodologies. He is funded by institutional grants, NIGMS, the DoD, and NIDA.
  • Brandon Sonn, MS